Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 0 | 119,110 | 94,850 | 111,980 | 66,940 |
| Cost of Goods | N/A | 59,690 | 53,150 | 39,960 | 27,310 |
| Gross Profit | N/A | 59,420 | 41,690 | 72,010 | 39,620 |
| Operating Expenses | 0 | 101,420 | 123,150 | 87,300 | 56,220 |
| Operating Income | N/A | -42,000 | -81,450 | -15,280 | -16,590 |
| Interest Expense | 0 | 11,730 | 8,010 | 7,180 | 7,180 |
| Other Income | 0 | 7,660 | 12,760 | 24,600 | 10,170 |
| Pre-tax Income | 0 | -46,070 | -76,700 | 2,140 | -13,600 |
| Income Tax | N/A | 470 | 420 | 360 | 100 |
| Net Income Continuous | N/A | -42,968 | -73,177 | 1,666 | -13,700 |
| Net Income | $N/A | $-46,550 | $-77,130 | $1,780 | $-13,710 |
| EPS Basic Total Ops | N/A | -0.80 | -1.20 | 3.00 | -2.61 |
| EPS Basic Continuous Ops | N/A | -0.71 | -1.19 | 3.00 | -2.61 |
| EPS Diluted Total Ops | N/A | -0.80 | -1.20 | 3.00 | N/A |
| EPS Diluted Continuous Ops | N/A | -0.71 | -1.19 | 3.00 | N/A |
| EBITDA(a) | $N/A | $-42,000 | $-81,450 | $-15,280 | $-4,110 |